BV 6
BV 6 性质
| 沸点 | 1376.7±65.0 °C(Predicted) |
|---|---|
| 密度 | 1.177±0.06 g/cm3(Predicted) |
| 储存条件 | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
| 溶解度 | DMSO 中≥60.28 mg/mL；不溶于水； ≥12.6 mg/mL，乙醇溶液（需要超声波） |
| 形态 | 固体 |
| 酸度系数(pKa) | 12.89±0.20(Predicted) |
| 颜色 | 白色至米白色 |
| InChIKey | DPXJXGNXKOVBJV-YLOPQIBLSA-N |
BV 6 用途与合成方法
IAP
Murine cIAP-1, cIAP-2 and XIAP expressions are clearly observed in the cytoplasm of both epithelial and stromal cells of implants, whereas Survivin is mainly expressed in the nuclei BV6 treatment for 4 weeks attenuated the intensity of IAPs expression. The size of lesions range from ~2 to 7 mm in diameter. The monolayer epithelial cell lining of the cyst is shown. After immunohistochemical staining, cytokeratin and vimentin are positively stained, whereas calretinin is negative. After BV6 treatment for 4 weeks, the total number of lesions (4.6 versus 2.8/mouse), the average weight (78.1 versus 32.0 mg/mouse) and the surface area (44.5 versus 24.6 mm 2 /mouse) of lesions are significantly less than in the controls. In the endometrial gland epithelia or stroma, the percentage of Ki67-positive cells decreases after BV6 treatment.
BV 6 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-06-05 | HY-16701 | 1001600-56-1 | 1 mg | 453 | |
| 2026-06-05 | HY-16701 | BV 6 | 1001600-56-1 | 2mg | 621 |
